Are pain coping strategies and neuropathic pain associated with a worse outcome after conservative treatment for Achilles tendinopathy? A prospective cohort study

Lagas, Iris F.; Vlist, Arco C van der; Oosterom, R.; Veldhoven, Peter L J van; Waarsing, J.H.; Bierma-Zeinstra, Sita M A; Verhaar, Jan A N; Vos, Robert‐Jan de

doi:10.1016/j.jsams.2021.04.001

Cited by 3 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While the presence of neuropathic pain in chronic tendinopathy has been proposed, the prevalence of neuropathic pain has not yet been studied in detail in clinical populations with tendinopathy. 50 However, a recent study suggests that presence of neuropathic pain is not associated with a worse clinical outcome in patients with Achilles tendinopathy 51 highlighting that further research is required in this arena.…”

Section: Pain Educationmentioning

confidence: 99%

Biopsychosocial approach to tendinopathy

Edgar

Clifford

O’Neill

et al. 2022

BMJ Open Sport Exerc Med

View full text Add to dashboard Cite

Tendinopathy describes a spectrum of changes that occur in damaged tendons, leading to pain and reduced function that remains extremely challenging for all clinicians. There is an increasing awareness of the influence that psychological and psychosocial components, such as self-efficacy and fear-avoidance, have on rehabilitation outcomes in musculoskeletal medicine. Although it is widely accepted that psychological/psychosocial factors exist in tendinopathy, there is currently a distinct lack of trials measuring how these factors affect clinical outcomes. Biopsychosocial treatments acknowledge and address the biological, psychological and social contributions to pain and disability are currently seen as the most efficacious approach to chronic pain. Addressing and modulating these factors are crucial in the pathway of personalised treatments in tendinopathy and offer a real opportunity to drive positive outcomes in patients. In this education review, we also provide the current evidence-based guidance on psychological and psychosocial developments in musculoskeletal medicine and how these may be translated to treating tendinopathy using a biopsychosocial model.

show abstract

Section: Pain Educationmentioning

confidence: 99%

Biopsychosocial approach to tendinopathy

Edgar

Clifford

O’Neill

et al. 2022

BMJ Open Sport Exerc Med

View full text Add to dashboard Cite

show abstract

“…Psychological factors were evaluated in 4% (11/307) of all studies (Table 2; Fig. 2) [4,80,87,108,171,173,179,280,290,309]. The Tampa Scale of Kinesiophobia was the most…”

Section: Psychological Factorsmentioning

confidence: 99%

ICON 2020—International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Nine core domains for tendinopathy have been identified. For Achilles tendinopathy there is large variation in outcome measures used, and how these fit into the core domains has not been investigated. Objective To identify all available outcome measures outcome measures used to assess the clinical phenotype of Achilles tendinopathy in prospective studies and to map the outcomes measures into predefined health-related core domains. Design Systematic review. Data Sources Embase, MEDLINE (Ovid), Web of Science, CINAHL, The Cochrane Library, SPORTDiscus and Google Scholar. Eligibility Criteria for Selecting Studies Clinical diagnosis of Achilles tendinopathy, sample size ≥ ten participants, age ≥ 16 years, and the study design was a randomized or non-randomized clinical trial, observational cohort, single-arm intervention, or case series. Results 9376 studies were initially screened and 307 studies were finally included, totaling 13,248 participants. There were 233 (177 core domain) different outcome measures identified across all domains. For each core domain outcome measures were identified, with a range between 8 and 35 unique outcome measures utilized for each domain. The proportion of studies that included outcomes for predefined core domains ranged from 4% for the psychological factors domain to 72% for the disability domain. Conclusion 233 unique outcome measures for Achilles tendinopathy were identified. Most frequently, outcome measures were used within the disability domain. Outcome measures assessing psychological factors were scarcely used. The next step in developing a core outcome set for Achilles tendinopathy is to engage patients, clinicians and researchers to reach consensus on key outcomes measures. Prospero Registration CRD42020156763.

show abstract

“…A sensibilização central é semelhante, com aumento da responsividade no sistema nervoso central, que está associada a um baixo limiar de dor. A sensibilidade dos neurônios de transmissão da dor é aumentada para vários estímulos periféricos, incluindo a pressão mecânica (LAGAS et al, 2021).…”

Section: Introductionunclassified

Fitocanabidióides como adjuvante ao tratamento de processos álgicos: uma revisão sistemática

Marques,

Alencar,

Nóbrega

et al. 2022

Rev. Bra. de Filo. e Hist.

View full text Add to dashboard Cite

Introdução: Muitas estratégias terapêuticas atuais são ineficazes devido à compreensão incompleta dos mecanismos envolvidos nas condições de dor crônica e neuropática, com isso, estudos sugerem que a Cannabis está sendo utilizada no tratamento dessas dores. Objetivo: Analisar, mediante revisão sistemática, se em pacientes com dores crônicas ou neuropáticas, o uso da cannabis associada ao tratamento convencional, quando comparada ao tratamento isolado, auxiliam na minimização do quadro álgico. Metodologia: Trata-se de uma Revisão Sistemática de Intervenção fundamentada na utilização de Ensaios Clínicos Randomizados. Os estudos foram avaliados através de diversos métodos de pesquisa e busca em bases de dados eletrônicas: Biblioteca Virtual em Saúde (BVS), Scientific Electronic Library Online (SciELo), Biblioteca Nacional de Medicina dos Estados Unidos da América (MEDLINE), Google Scholar e Physiotherapy Evidence Database (PEDro). A pesquisa incluiu ligando os seguintes Descritores em Ciências da Saúde em português: “dor crônica e neuropática” e “cannabis” ou “Canabidiol” e “tratamento convencional”. Esses descritores foram utilizados em associação com os operadores lógicos booleanos “AND”. As buscas resultaram em 376 artigos, dos quais 12 foram utilizados para a composição do estudo. Resultados: Ficou evidente que a cannabis é uma opção de tratamento coadjuvante, mostrando eficácia na terapia de dores crônicas e neuropáticas. Além disso, atua melhorando quadros em pacientes com câncer avançado que tem uma importância significativa para o levantamento de evidências que permitam a elaboração de alguns dados sobre dosagem e formulação de canabidiol especificamente. Conclusão: A cannabis pode ser considerada um forte adjuvante no tratamento da dor crônica e neuropática.

show abstract

Are pain coping strategies and neuropathic pain associated with a worse outcome after conservative treatment for Achilles tendinopathy? A prospective cohort study

Cited by 3 publications

References 30 publications

Biopsychosocial approach to tendinopathy

Biopsychosocial approach to tendinopathy

ICON 2020—International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy

Fitocanabidióides como adjuvante ao tratamento de processos álgicos: uma revisão sistemática

Contact Info

Product

Resources

About